Summary
Introduction
Penicillin-binding proteins (PBPs) , the target enzymes for p-lactam antibiotics, are minor components of the bacterial cytoplasmic membrane. They function in the late steps of murein biosynthesis, and therefore their active centre is on the outer surface of the cytoplasmic membrane, p-lactams inactivate the PBPs by acylating an essential serine residue in the active site of these proteins. Whereas inhibition of \ow-Mr PBPs, vi/hich are D-aianyl-Dalanine-carboxypeptidases, can be tolerated by the bacteria, inhibition of high-Mr PBPs, which are assumed to be transpeptidases. is lethal to the cells. Based on the sequences of their penicillin-binding domains, all PBPs are thought to be related to each other; they form, together with the penicillin-hydrolysing enzymes (p-lactamases), a superfamily of active-site serine, penicillin-recognizing proteins (Jorisef a/., 1988) . Much, however, remains to be learned about the evolutionary relationships among the PBPs, primarily because of the lack of information about the sequences and overall structures of the high-M, PBPs of different species.
Streptococcus pneumoniae contains six PBPs (Hakenbeck et al., 1986) . The five high-M, PBPs 1 a, 1 b, 2x, 2a and 2b, ranging from 92 to 78kD, are of unknown function, whereas the 43 kD low-M, PBP3 acts in vitro as a D,D-carboxypeptidase (Hakenbeck and Kohiyama, 1982) . Penicillin resistance in pneumococci can be acquired by the stepwise accumulation of mutations in at least the three high-M^ PBPs la, 2xand 2b (Hakenbeck etai, 1980; Zighelboim and Tomasz, 1980; Hakenbeck ef al.. 1988) . In earlier papers, only five PBPs were detected using different SDS-PAGE systems, and alterations were also shown to occur in a so-called PBP2a; however, we believe that this protein was actually PBP2x. Penicillin resistance can also be obtained by the stepwise transformation of sensitive strains using the DNA from resistant strains that have been isolated in clinics or produced in the laboratory (Shockley and Hotchkiss, 1970) . In this process, the transformants successively acquire the altered PBPs of the donor strain (Zighelboim and Tomasz, 1980) . Since these PBP alterations lead to a decrease in affinity for p-lactams. characterization of the mutations involved will help to identify the protein regions responsible for the interaction with p-lactam antibiotics.
The problems of analysing these mutations in clinical isolates is at least two-fold: the strains are not Isogenic, and the mechanism responsible for evolution of lowaffinity PBPs is not known. Gene sequencing has revealed that PBPs from penicillin-resistant clinical isolates of Neisseria gonorrhoeae {PBP2) (Spratt, 1988) and S. pr^eu-moniae (PBP2b) (Dowson et al., 1989) have extensive alterations in their primary structure, thus aggravating the identification of those mutations that contribute to the decrease in penicillin affinity. We have therefore isolated a series of spontaneous, independent, laboratory mutants with increasing resistance to either piperacillin or cefotaxime {Laible and . Cefotaxime resistance leads to affinity changes primarily of PBP2a and PBP2x. Using cefotaxime resistance as selective marker in transformation experiments, we have been able to identify the DNA coding for PBP2x. The gene and surrounding regions were sequenced, and the mutations responsible for cefotaxime resistance in the laboratory mutant C506 were identified. The deduced amino acid sequences of PBP2x were used for comparative analysis with PBPs of other bacterial species.
Results and Discussion
Isolation of the pbpX gene of S. pneumoniae
In the cefotaxime-resistant mutant, C506. PBP2x and PBP2a have reduced affinity for (i-lactams (Laible and Hakenbeck, 1987) . The strategy used for cloning the pbpX gene was based on identification of DNA fragments capable of transforming penicillin-sensitive strains 801 (which carries a hex~ mutation) or R6 to cofotaxime resistance. No attempts were made to clone the gene directly into E. coli since unstable clones are frequently observed probably because of promoter-bearing regions in the AT-rich pneumococcal DNA (StassI and Lacks, 1982) .
After SamHI-digestion of chromosomal C506 DNA, the 2.3-3.6kb DNA fraction could transform strain 801 to cefotaxime resistance (0.06^.g ml'^) and was cloned into plasmid pSP2. pSP2, carrying an erythromycin resistance marker, is stable in pneumococci only as a recombinant plasmid because of long inverted repeats (Prats et al.. 1985) . After transformation of 801 with the recombinant plasmids, no transformants could be selected using erythromycin plus cefotaxime, indicating that cefotaxime resistance is not expressed. Therefore, erythromycinresistant transformants were isolated and replated on plates containing cefotaxime alone. Clones containing recombinant pSP2 carrying the cefotaxime resistance marker should be able to produce cefotaxime-resistant colonies at low frequency because of homologous recombination with the chromosomal pbpX wild-type gene. Fifteen out of 200 erythromycin-resistant transformants produced cefotaxime-resistant colonies and contained the same pSP2 derivative, pPGI. with a 2.6kb SamHI insert. The cefotaxime-resistant transformants in which part of the genome had been replaced by recombination with the 2.6 kb fragment of C506 contained a low-affinity PBP2x (Fig. 1 ), demonstrating that part or all of the pbpX gene is located on pPGI.
Digestion of the 2.6kb BamHI insert with EcoRI produced two fragments. After transformation of the 801 recipient strain by either one of the fragments, only the smaller one (0.8 kb) yielded cefotaxime resistance. Sequencing of this 0.8kb EcoRI-BamHI fragment revealed an open reading frame which terminated 60 nucleotides upstream from the EcoRI site and continued through the SamHI site, indicating that the C-terminal part of the PBP2x gene had been cloned.
The wild-type pbpXgene was then isolated in two steps using the 2.6kb SamH! fragment from C506. In the first step, the 1.8kb EcoRI/SamHI portion of this fragment, downstream from pbpX, was inserted into pR28, and this construct, pCG4, was inserted into the chromosome of strain 801 by homology-dependent integration (Fig. 2) . A second recombinant plasmid, pCG6, was then isolated from the chromosome using Pst\ restriction endonuclease. In the second step, the 0.4kb EcoVN-Pst\ fragment was removed from pCG6 and was used as a hybridization probe on R6 DNA digested with Dra\l EcoF\y. A 2.4kb fragment was found, which presumably carried the promoter region. It was cloned into plasmid pJDC9, in which strong terminators surrounding the cloning site should facilitate cloning of pneumococcal promoter sequences into E. coti {Chen and Morrison, 1987) . The restriction endonuclease cleavage map of the pbpX region is shown in Fig. 3 . The 2250-nucleotide open reading trame of the pbpX gene encoded 750 amino acid residues {Fig. 4). It was preceded by an open reading frame, and another open reading frame started almost immediately after termination of the pbpXgene {Fig. 3). No other long open reading frames were found. Potential candidates for Shine-Dalgarno and promoter sequences were identified using E. colt consensus sequences. A putative rho-independent terminator region was found following the terminator codon, TAA {Fig. 4).
No differences between the nucleotide sequences of the pbpX genes of strains R6 and 801 were detected. The sequence obtained from mutant C506 differed in three nucleotides from R6 or 801. changing Met2B9 into Thr and the closely linked Gly597 and Gly601 into Val597 and Asp601, respectively (Fig. 4) . Between the A/terminus and Met289, no mutations were found even In more highly resistant mutants derived from C506.
The codon usage was very similar to that of the gene encoding the pneumococcal high-M, PBP2b, which has been partly sequenced recently {Dowson et ai, 1989), but not to the highly expressed lytA gene coding for the major autolysin of S. pneumoniae {Garcia et ai. 1986) {not shown). Marked differences were found in the codon usages for Gly, Asp, Tyr, Phe, Ser and His, probably reflecting the more frequent use of modulator codons in weakly expressed genes, as has been suggested for E. coli PBPs {Asoh etai. 1986 ).
The M, of PBP2X, according to the derived amino acid sequence, is 82.35 kD. a value which is in agreement with an M, of approximately 80-85 kD, as derived from SDSgel electrophoresis.
Conserved boxes in the amino acid sequence of PBP2x
On the basis of homology searches and aminc acid alignment, several conserved regions have been identified among the p-lactamases, low-M, PBPs and penicillinbinding domains of the high-M, PBPs {Joris ef ai, 1988) . • i t - 
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Rg. 5. Predicted secondary structures and hydrophobicity (a, b) The active-site serine is always part of the sequence SXXK (box II) and, at a certain distance from the Cterminus, one of the triad KTG, KSG or HTG (box VII) can be found. Recently, an SXN motif was identified on the carboxyternninal side of the active-site serine (Spratt and Cromie, 1988) . In S. pneumoniae PBP2x, STMK 337-340 is thought to contain the active-site serine and KSG 547-549 is assumed to be the conserved triad HTG/KTG/KSG for the following reasons, (i) S337 is at the amino terminus of a hydrophobic stretch with a high (t-helix potential (Fig. 5) . The occurrence of the active-site serine at the end of an «-helix is expected from the three-dimensional data obtained trom the crystal structure of Streptomyces R61 PBP (Kelly e( ai.. 1988) . (ii) S395SN is 58 amino acids downstream of the STMK-sequence, corresponding to the reported 47-62 amino acid distance in other high-M, PBPs (Spratt and Cromie, 1988) . (iii) The size of the stretch S337TVIK to K547SG (i.e. 210 amino acids) is that expected for a penicillin-binding domain (Table 1) . In this table, and as proposed by Joris ef al. (1988) , the penicillinbinding domain of the PBPs is defined as a polypeptide stretch that starts 60 residues (or less) upstream of the active-site serine and terminates 60 residues {or less) downstream of the H or K of the conserved box VII. This pattern allows definition of an amino-terminal extension and a carboxy-terminal extension on both sides of the penicillin-binding domain. All the (i-lactamases of classes A, C and D lack any N-or C-terminal extension (not shown). The low-and high-M, PBPs have a C-terminal extension of varying length, except the Streptomyces R61 PBP, which is excreted dunng growth (Duez ef al., 1987) and, interestingly, the PBP2b of S, pneumoniae {Dowson ef al.. 1989). Only the high-/W, PBPs have a long aminoterminal extension.
Membrane topology of PBP2x
Figure 5 reveals that one predominant region with a high hydrophobicity index occurs close to the amino terminus. The amino-terminal 100 amino acid region was reexamined using both the Kyte-Doolittle procedure (1982) and the Engelman-Steitz-Goldman program (1986) for identifying transmembrane segments. The two profiles (Fig. 5 ) strongly suggest that PBP2x is anchored into the membrane by amino acids L30-I48. It should be noted that the same stretch has a high «-helix potential according to the program of Garnier ef al. {1978). This hydrophobic portion is preceded by a terminal hydrophilic as well as a basic region {known features of signal peptides) (von Heijne, 1985) . On the basis of the amino acid sequence, no cleavage site for a signal peptidase was found. We therefore assume that the mature form of PBP2x contains an unprocessed signal sequence followed by a membrane-anchoring segment, as has been shown for E coii PBPIb (Spratt ef a/., 1987) and PBP2 (Asoh e^ al., 1986) . In contrast, E coli PBP3 is probably processed after synthesis (Nakamura et al.. 1983 ) and membrane binding might be mediated through modification of a cysteine residue with a lipid moiety (Hayashi ef a/., 1988) . If the membrane topology proposed for PBP2x IS correct, then that portion of the amino-terminal extension which occurs upstream of the penicillin-binding domain and which might have some enzymatic function would be the 227 amino acid stretch, T50-M277.
Homology searches
The amino acid sequences of all the PBPs listed in Table 1 were compared pair-wise using the Goad and Kanehisa procedure (1982) and the SEQHP and SEODP programs (for more details, see Joris ef a/., 1988). For each pair of PBPs, the amino-terminal extensions (for the high-Mr PBPs) and the penicillin-binding domains, as defined in Table 1 , were analysed separately. The procedure yields a score and a standard deviation unit (SDU). The more negative the score, the better the homology. An SDU value of five or higher indicates a statistically significant homology. The results of this analysis are shown in Fig. 6 . It should be noted that part of the /V-terminal sequence of pneumococcal PBP2b is absent.
The data show that PBP2x is related to all the other high-M, PBPs, with the exception of E coli PBPs l a and 1b. These two proteins are highly homologous in their amino-terminal extensions, as has been reported previously (Broome-Smith etai.. 1985; Joris etai.. 1988) , and both are known to perform transglycosylation in vitro (Tomioka et al.. 1982; Nakagawa et al.. 1984) . No significant homology between high-and low-M, PBPs was detected. Interestingly, the penicillin-binding domain of PBP2x is especially closely related to those of E coli PBP3, N. gonorrhoeae PBP2 and S. pneumoniae PBP2b. In contrast, the amino-terminal extension of PBP2x is closely related to those of E coli PBP2 and methicillinreslstant S. aureus PBP2'. It can be speculated that the A/-terminal extension and the penicillin-binding domain of PBP2X have evolved independently from each other.
Comparison with E. coli PBP3
The two sequences of PBP2x and E coti PBP3 have been aligned using the BESTFIT program (Fig. 7) . In this alignment, the only short gap introduced in the sequence of PBP2x is N441. . .1442. The two amino-terminal extensions {PBP2x, 1^277) contain 48 identities (17%) and two highly homologous stretches. The two penicillin-binding domains (278-*607) contain 80 identities (24%) and seven highly homologous stretches.
The homology found between these two proteins does not necessarily indicate any similarity in their respective enzymatic activity in vivo, or affinity for [i-lactams. The high in vivo affinity of the E coli PBP3 for aztreonam (binding occurs at 0.01 ng ml ^) (Briese etai, 1988) was not found with the pneumococcal PBP2x {1 |i.g m l " ' and higher), and the related pneumococca! PBP2b does not bind aztreonam at all (Hakenbeck et ai, 1987) .
Analysis of mutations in C506
The three point mutations found in PBP2x of the cefotaxime-resistant mutant. C506 (i.e.. M289-.T; G597^D; G601 -^V) are located at both ends of the penicillin-binding domain (Figs 4 and 7) . We believe that the mutations, or some of them, are responsible for p-lactam resistance in that they decrease penicillin affinity or stabilize an already mutated PBP2x. The contribution of the individual mutations to [i-lactam resistance is currently under investigation. Since PBP2x appears to be an essential protein, the mutations are unlikely to affect its actual enzymatic function. The PBP2x mutations in C506 occur close to amino acid stretches that are highly homologous to other PBPs (Fig. 8) . The Val284 to Asp313 sequence of PBP2x shares homology even with the corresponding regions of the E. coli PBPs 1a and 1b, which in turn reveal high homology with that of the E coli PBP2 (see also Fig. 6 ). It is striking that the mutated positions found in PBP2x are almost identical to those found in E coii PBP3 of low-level cefalexin-resistant mutants isolated after mutagenesis (A257--V; V545-^l), and that among the mutations inactivating PBP3 without impairing its ability to bind penicillin, substitutions in G542 as well as A547 were found (Hedge and Spratt, 1985a; 1985b) (Fig. 8) . This region also corresponds to a peptide stretch that appeared highly mutated In the resistant gonococcal strains (Spratt, 1988) . It is likely that the homologous peptide stretches belong to preserved three-dimensional structures that occupy important positions, and that the mutations fall into nearby variable loops important for access of (J-lactam antibiotics. 
Experimental procedures

Bacterial strains, growth conditions, plasmids and bacteriophages
S. pneumoniae R6 is a penicillin-sensitive, non-encapsulated laboratory strain (Ottolenghi and Hotchkiss. 1962} with an MIC value for cefotaxime of 0.02 jxg ml '. The other pneumococcal strains used are derivatives of strain R6. C506 is a spontaneous cefotaxime-resistant mutant isolated after five selection steps on increasing concentrations of cefotaxime (MiC for cefotaxime: 1.28M.g m|-^) (Laible and Hakenbeck, 1987) . Strain 801 is an R6 derivative carrying a rtex mutation and is therefore defective in the mismatch repair process (Levefre ef ai.. 1979) . Cells were cultivated in C-medium supplemented with 0.2% yeast extract (Lacks and Hotchkiss, 1960) at 3 7 X without aeration. E. coli JM103 (Messing etai.. 1981) was used for growth of phagescript SK (Stratagene: San Diego. CA) and M13mp8/mp9 phages {Messing and Vieira. 1982). and E. coii DH5 was used for propagation of E. coii plasmids. Plasmids pJDC9 (Chen and Morrison. 1987) , pSP2, which can be used for direct selection of recombinant plasmids (Prats ef ai., 1985) , and pR28, which cannot be maintained autonomously in pneumococci (Mejean ef al., 1981) have been described.
Transformation
Transformation of S. pneumoniae strains was carried out according to Tiraby and Fox (1974 The PBP2b gene of one highly penicillin-resistant pneumococcal strain contains a vast number of nucleotide changes (74) coding for 17 amino acid substitutions (Dowson etai., 1989) . Similarly, a highly altered PBP gene occurs in resistant gonococci (Spratt, 1988) . It would be of interest to search in the pneumococcal strains for alterations that Vkfould occur in PBP2x, and to compare the alterations found in laboratory mutants with those present in clinical isolates. It will also be important to localize the mutations in the PBP2x gene in cefotaxime-resistant mutants isolated independently from the one described here, and to determine whether there is a specific order of mutations that leads to decreased affinity for a given antibiotic. were screened on plates containing 0.06 fig ml ' cefotaxime, and erythromycin-resistant colonies were isolated using 5p.g ml ' erythromycin. Transformation of E. coli strains was performed using gradient-purified plasmid DNA and CaCl2-treated cells (Browner a/,. 1979 ).
Assay of PBPs
PBPs were visualized after incubation of cell lysates with pH]-propionylampicillin, followed by SDS-polyacrylamide gel electrophoresis and fluorography as described (Laible and Hakenbeck, 1987) .
Preparation of pneumococcal chromosomal DNA
Pneumococci were harvested by centrifugation at late-exponential growth phase. Cells were resuspended in 0.1 M EDTA, 0.005% deoxycholate, 0.01% SDS, pH 8.0 and lysed during incubation at 37°C for 5 min. After ethanol-precipitation, DNA fibres were collected and resuspended in 0.03 M sodium citrate, pH 8.5. Following treatment with proteinase K (80 ^g m! ') for 30 min at 37"C. phenol-extraction and ethanol-precipitation, DNA was resuspanded in lOmM Tris-HCI. i m M EDTA, pH 7.5, at about 200 M.g ml '.
Isolation of plasmids from S. pneumoniae
Plasmids were prepared from pneumococci essentially as described by Bimboim and Doly (1979) .
Southern blots and colony hybridization
Restriction endonucleases were obtained from commercial sources. Restricted DNA fragments were eluted from agarose gels by the method of Vogelstein and Gillespie (1979) . For Southern blot hybridizations. ^^P nick-translated DNA was used.
Colony hybridization was performed with random primed DNA fragments using a non^radioactive labelling and detection kit (Boehringer: Mannheim. FRG).
Sequencing of the PBP2x gene from S. pneumoniae
The 0.8kb EcoRl-SamHI insert of the recombinant plasmid pPGI was subcloned into M13mp8/mp9. From the 1.8kb EcoRI/Psfl insert of plasmid pCG6 (Fig. 3) . unidirectional deletions were generated in the Ml3-derived vector phagescript SK using Exolll and SI nuc!ease (Guoefa/., 1983) . The 2.4 kb EcoRV/Dralinsen of pCG8 {Fig. 3) was subcloned in pJDC9 and sequenced in the plasmid (Chen and Seeburg, 1985) .
Reagents and generai techniques
Restriction enzymes. T4 DNA ligase, and alkaline phosphatase were purchased from Boehringer (Mannheim. FRG), BRL (Gaithersburg, MD, USA) and New England Biolabs (Beverly. MA, USA) and used as described by the suppliers. Sequenase was from the United States Biochemical Corporation (Cleveland, OH, USA). All molecular manipulations were performed using standard procedures (Maniatis et al.. 1982) unless otherwise stated. Nucleotide sequencing was carried out by the chain-termination method (Sanger ef al.. 1977) using PS]-dATP obtained from Amersham-Buchler (UK) in the sequenase reaction (Tabor and Richardson. 1987 ) and standard oligodeoxynucleotide primers.
